Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Targeted Oncology|June 14, 2011
Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancerMarco Platania, Francesco Agustoni, Barbara Formisano, et al.
Therapeutic Advances in Medical Oncology|March 28, 2017
Everolimus treatment for neuroendocrine tumors: latest results and clinical potentialSara Pusceddu, Elena Verzoni, Natialie Prinzi, et al.
Endocrine|January 24, 2025
Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoidsLinda Galvani, Arianna Zappi, Sara Pusceddu, et al.
Journal of Clinical Medicine|September 9, 2023
Multidisciplinary Approach to the Diagnosis of Occult Primary Neuroendocrine Neoplasm: A Clinical ChallengeRoberta Elisa Rossi, Francesca Corti, Sara Pusceddu, et al.
Scandinavian Journal of Gastroenterology|August 28, 2019
Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasmFederica Cavalcoli, Sara Pusceddu, Alessandra Zilli, et al.
Scientific Reports|July 9, 2024
Cylindrical TGR as early radiological predictor of RLT progression in GEPNETs: a proof of conceptFederica Scalorbi, Enrico Matteo Garanzini, Giuseppina Calareso, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Pathological Characteristics, Management, and Prognosis of Rectal Neuroendocrine Tumors: A Retrospective Study from a Tertiary HospitalFederica Cavalcoli, Emanuele Rausa, Davide Ferrari, et al.
Cancers|December 19, 2020
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled TrialsAntonio Facciorusso, Mohamed A Abd El Aziz, Nicola Tartaglia, et al.
Endocrine|November 19, 2017
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter studyDavide Campana, Thomas Walter, Sara Pusceddu, et al.
Cancers|June 19, 2024
Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future PerspectivesFrancesca Corti, Roberta Elisa Rossi, Pietro Cafaro, et al.
Pageof 12